切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2008, Vol. 02 ›› Issue (05) : 1 -5. doi: 10.3877/cma.j.issn.1674-0807.2008.05.001

专家论坛

乳腺癌保乳治疗的患者选择
张保宁1,(), 张柏林1   
  1. 1.100021 北京,中国医学科学院肿瘤医院腹部外科乳腺疾病诊治中心
  • 收稿日期:2008-07-30 出版日期:2008-10-01
  • 通信作者: 张保宁

Patient selection for breast conserving therapy of breast cancer

Bao-ning ZHANG(), Bai-lin ZHANG   

  • Received:2008-07-30 Published:2008-10-01
  • Corresponding author: Bao-ning ZHANG
引用本文:

张保宁, 张柏林. 乳腺癌保乳治疗的患者选择[J/OL]. 中华乳腺病杂志(电子版), 2008, 02(05): 1-5.

Bao-ning ZHANG, Bai-lin ZHANG. Patient selection for breast conserving therapy of breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2008, 02(05): 1-5.

[1]
Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics,2002. CA Cancer J Clin,2005,55:74 -108.
[2]
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008.CA Cancer J Clin,2008,58:71 -96.
[3]
张思维,陈万青,孔灵芝,等. 中国部分市县1998 ~2002 年恶性肿瘤的发病与死亡.中国肿瘤,2006,15:430 -448.
[4]
Early Breast Cancer Trialists'Collaborative Group (EBCTCG).Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet,2005,365:1687 -1717.
[5]
Arriagada R,Lê MG,Rochard F,et al. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol,1996,14:1558 -1564.
[6]
Early Breast Cancer Trialists'Collaborative Group. Effects of radiotherapy and surgery in early breast cancer:an overview of the randomized trials. N Engl J Med,1995,333:1444 -1455.
[7]
Fisher B,Anderson S,Bryant J,et al.Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy,and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med,2002,347:1233 -1241.
[8]
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med,2002,347:1227 -1232.
[9]
Abrams J S, Philips P H, Friedman M A. Meeting highlights:a reappraisal of research results for the local treatment of early stage breast cancer. J Natl Cancer Inst,1995,87:1837 -1845.
[10]
Dalberg K, Mattsson A, Rutqvist L E, et al. Breast conserving surgery for invasive breast cancer: risk factors for ipsilateral breast recurrences. Breast Cancer Res Treat,1997,43:73 -86.
[11]
NIH Consensus Conference. Treatment of early stage breast cancer. JAMA,1991,265:391 -395.
[12]
张保宁,邵志敏,乔新民,等.中国乳腺癌保乳治疗的前瞻性多中心研究.中华肿瘤杂志,2005,27:680 -684.
[13]
张保宁.乳腺癌保乳手术临床应用现状与发展趋势.中国实用外科杂志,2008,28:528 -524.
[14]
Borger J, Kampermann H, Hart A, et al. Risk factors in breast-conservation therapy. J Clin Oncol,1994,12:653 -660.
[15]
Kurtz J M, Jacquemier J, Amalric R, et al. Why are local recurrences after breast-conservation therapy more frequent in younger patients? J Clin Oncol,1990,8:591 -598.
[16]
Veronesi U,Luini A,Del Vecchio M,et al. Radiotherapy after breast-preserving therapy in women with localized cancer of the breast. N Engl J Med,1993,328:1587 -1591.
[17]
Vilcoq J, Calle R, Stacey P, et al. The outcome of treatment by tumorectomy and radiotherapy of patients with operable breast cancer. Int J Radiat Oncol Biol Phys, 1981,7:1327 -1332.
[18]
Fourquet A, Campana F, Zafrani B,et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys,1989,17:719 -725.
[19]
Fisher B, Wickerham D L, Deutsch M, et al. Breast tumor recurrence following lumpectomy with and without breast irradiation: an overview of recent NSABP findings. Semin Surg Oncol,1992,8:153 -160.
[20]
Winchester D P. Breast cancer in young women. Surg Clin North Am,1996,76:279 -287.
[21]
Vezeridis M P, Bland K I. Surgical and medical management of in situ and early stage breast carcinoma. In:Singletary SE,ed.Breast cancer. New York: Springer,1999:132 -148.
[22]
Schwartz G F, Veronesi U, Clough K B, et al. Consensus Conference Committee. Consensus conference on breast conservation. J Am Coll Surg,2006,203:198 -207.
[23]
Fitzal F,Riedl O,Wutzl L,et al. Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients. Breast Cancer Res Treat,2007,103:45 -52.
[24]
Liljegren G, Lindgren A, Bergh J, et al. Risk factors for local recurrence after conservative treatment in stage I breast cancer:definition of a subgroup not requiring radiotherapy. Ann Oncol,1997,8:235 -241.
[25]
Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumor recurrence after lumpectomy. Lancet,1991,338:327 -331.
[26]
Gazet J C. Future prospects in limited surgery for early breast cancer. Semin Surg Oncol,1996,12:39 -45.
[27]
Soran A, Vogel V. Optimal management of primary breast cancer. Breast J,1999,5:81 -93.
[28]
Danoff B,Goodman RL. Identification of a subgroup of patients with breast cancer in whom conservative surgery and radiation is contraindicated. Int J Radiat Oncol Biol Phys,1985,11 (suppl 1):104.
[29]
Ueda S, Tamaki Y, Yano K, et al. Cosmetic outcome and patient satisfaction after skin-sparing mastectomy for breast cancer with immediate reconstruction of the breast. Surgery,2008,143:414 -425.
[30]
Patani N, Devalia H, Anderson A, et al. Oncological safety and patient satisfaction with skin-sparing mastectomy and immediate breast reconstruction.Surg Oncol, 2008,17:97 -105.
[31]
Recht A,Danoff B S,Solin L J,et al. Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation. J Clin Oncol,1985,3:1339 -1343.
[32]
Wong R K M, Banducci D R, Feldman S, et al. Prereconstruction tattooing eliminated the need for skin grafting in nipple areolar reconstruction. Plast Reconstr Surg,1993,92:547 -549.
[33]
Kurtz J, Jacquemier J, Amalric R, et al. Breast conserving therapy for macroscopically multiple cancers. Ann Surg,1990,212:38 -44.
[34]
Leopold K A, Recht A, Schnitt S J, et al. Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast. Int J Radiat Oncol Biol Phys,1989,16:11 -16.
[35]
Winchester D P, Cox J D. Standards for breast-conservation treatment. CA Cancer J Clin,1992,42:134 -162.
[36]
Recht A. Patient selection for treatment with conservative surgery and radiation therapy. Cancer Invest, 1992,10:471 -476.
[37]
Fleck R,Mc Neese M D, Ellerbroek N A,et al. Consequences of breast irradiation in patients with pre-existing collagen vascular disease. Int J Radiat Oncol Biol Phys,1989,17:829 -833.
[38]
Robertson J G, Clarke D H, Pevzner M M, et al. Breast conservation therapy: severe breast fibrosis after radiation therapy in patient with collagen-vascular disease. Cancer,1991,68:502 -508.
[39]
Ross J G, Hussey D H, Mayr N A, et al. Acute and late reactions to radiation therapy in patients with collagen vascular diseases. Cancer,1993,71:3744 -3752.
[40]
Recht A. Selection of patients with early stage invasive breast cancer for treatment with conservative surgery and radiation therapy. Semin Oncol,1996,23:19 -30.
[41]
Winchester D P, Cox J D. Standards for diagnosis and management of invasive breast carcinoma. American College of Radiology. American College of Surgeons. College of American Pathologists. Society of Surgical Oncology. CA Cancer J Clin,1998,48:83 -107.
[42]
Marcus J N, Watson P, Page D L, et al. Pathology and heredity of breast cancer in younger women. Monogr Natl Cancer Instit,1994,16:23 -34.
[43]
Chabner E, Nixon A, Gelman R, et al. Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol,1998,16:2045 -2051.
[44]
Claus E B. The genetic epidemiology of breast cancer in younger women. Monogr Natl Cancer Inst,1994,16:49 -53.
[45]
Easton D. Breast cancer genes-what are the real risks? Nat Genet,1997,16:210 -211.
[46]
Narod SA. Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer,2002,2:113 -123.
[47]
Sakorafas G H, Tsiotou A G. Genetic predisposition for breast cancer from a surgical perspective. Br J Surg,2000,87:149 -162.
[48]
Winchester D P, Cox J D. Standards for diagnosis and management of invasive breast carcinoma. CA Cancer J Clin,1998,48:83 -107.
[49]
Sadowsky N L, Semine A, Harris J R. Breast imaging: a critical aspect of breast conserving treatment. Cancer,1990,65:2113 -2118.
[50]
Monsees B S. Evaluation of breast microcalcifications. Radiol Clin North Am,1995,33:1109 -1121.
[51]
Bhattacharyya M, Ryan D, Carpenter R, et al. Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer. Br J Cancer,2008,98:289-293.
[52]
Van Goethem M, Schelfout K, Kersschot E, et al. MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component. Eur J Radiol,2007,62:273 -282.
[53]
张保宁,张慧明.我国乳腺癌保乳手术应注意的几个问题.中华医学杂志.2008,88:73 -76.
[54]
Holland R, Connolly J L,Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol,1990,8:113 -118.
[55]
Lagios M D, Westdahl P R, Margolin F R, et al. Ductal carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity,lymph node metastases, and short-term treatment failures. Cancer,1982,50:1309 -1314.
[56]
O'Sullivan M J,Li T,Freedman G,et al. The effect of multiple reexcisions on the risk of local recurrence after breast conserving surgery. Ann Surg Oncol,2007,14:3133 -3140.
[57]
McIntosh A, Freedman G, Eisenberg D, et al. Recurrence rates and analysis of close or positive margins in patients treated without re-excision before radiation for breast cancer. Am J Clin Oncol,2007,30:146 -151.
[58]
Zafrani B, Vielh P, Fourquet A, et al. Conservative treatment of early breast cancer: Prognostic value of the ductal in situ component and other pathological variables on local control and survival: Long-term results. Eur J Cancer Clin Oncol,1989,25:1645 -1650.
[59]
Harris J R. Breast-conserving therapy as a model for creating new knowledge in clinical oncology. Int J Radiat Oncol Biol Phys,1996,35:641 -648.
[60]
Horst K C, Smitt M C, Goffinet DR, et al. Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer,2005,5:425 -438.
[61]
Smitt M C, Nowels K, Carlson R W, et al. Predictors of reexcision findings and recurrence after breast conservation. Int J Radiat Oncol Biol Phys,2003,57:979 -985.
[62]
Fitzal F, Gnant M. Breast conservation: evolution of surgical strategies. Breast J,2006,12(5 Suppl 2):S165 -S173.
[63]
Hunt K K, Ames F C, Singletary S E, et al. Locally advanced noninflammatory breast cancer. Surg Clin North Am,1996,76:393 -410.
[64]
Ogston K N, Miller I D, Payne S, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast,2003,12:320 -327.
[65]
Gralow J R, Burstein H J, Wood W, et al. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease. J Clin Oncol,2008,26:814 -819.
[66]
Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on localregional disease in women with operable breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol, 1997,15:2483 -2493.
[67]
Fisher B, Wolmark N, Mamounas E, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol,1998,16:2672 -2685.
[68]
van der Hage J A, van de Velde C J, Julien J P, et al.Preoperative chemotherapy in primary operable breast cancer.results from the European Organization for Research and Treatment of Cancer Trial 10902. J Clin Oncol, 2001,19:4224 -4237.
[69]
Wolff A C, Berry D, Carey L A, et al. Research issues affecting preoperative systemic therapy for operable breast cancer. J Clin Oncol,2008,26:806 -813.
[70]
Buchholz T A, Lehman C D, Harris J R, et al. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol,2008,26:791 -797.
[1] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[2] 赵阳, 肖迎聪, 巨艳, 党晓智, 蔡林利, 薛文欣, 李洋, 肖瑶, 郭妤绮, 宋宏萍. 自动乳腺超声联合免疫组化早期预测乳腺癌新辅助化疗病理完全缓解的临床价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(04): 361-369.
[3] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[4] 杨柳, 宋振川, 王新乐. 乳腺癌改良根治术联合背阔肌复位的临床疗效评估[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 269-273.
[5] 牛海刚, 郭文科. 三阴性乳腺癌组织中双特异性磷酸酶14与核受体相互作用蛋白1的表达及预后价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(04): 199-205.
[6] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[7] 宋佳, 汪波, 孙凯律, 商江峰, 吴旦平, 肇毅. 吲哚菁绿荧光显影联合亚甲蓝染色在乳腺癌前哨淋巴结活检中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 498-501.
[8] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[9] 唐丹萍, 王萍, 江孟蝶, 杨晓蓉. 自体脂肪移植在乳腺癌术后乳房重建的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 582-585.
[10] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[11] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[12] 王帅, 张志远, 苏雨晴, 李雯雯, 王守凯, 刘琦, 李文涛. 孟德尔随机化及其在乳腺癌研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 671-676.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[15] 张梦婷, 穷拉姆, 色珍, 李逸群, 德庆旺姆. 西藏地区藏族乳腺癌新辅助化疗的真实世界研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 441-446.
阅读次数
全文


摘要